Key Takeaways
- • abrdn Real Estate Fund accumulated 40,579 shares of American Healthcare REIT (AHR) through three purchases in 2024-2026 at an average price of $16.17, with subsequent partial exits reducing position to approximately 33,451 shares following two sales at an average price of $33.62.
- • American Healthcare REIT trades at $49.60 (as of April 30, 2026) with a market capitalization of $9.52 billion, representing a 52-week trading range of $32.15–$54.67 and a 1-year analyst price target of $57.92.
- • AHR operates a diversified healthcare real estate portfolio of approximately 22.16 million square feet as of December 31, 2025, with trailing twelve-month revenue of $2.26 billion and earnings per share of $0.42.
- • Top institutional shareholders include The Vanguard Group (13.02%), BlackRock (12.83%), Wellington Management Group (4.13%), and Principal Global Investors (3.70%), with a total of 532 institutional owners holding positions.
- • Truist Securities maintained a "Buy" rating on March 13, 2026, raising its price target from $52 to $57, citing AHR's strong market position and competitive advantage in healthcare real estate despite regulatory risks and tenant concentration concerns.
Summary
abrdn Real Estate Fund initiated a position in American Healthcare REIT, Inc. (NYSE: AHR) during the second quarter of 2024, establishing what would become a strategic healthcare real estate holding. The fund executed three separate purchases of AHR shares at an average entry price of $16.17, accumulating 40,579 shares across the 2024-2026 period. Subsequently, abrdn completed two partial exits at an average selling price of $33.62, reducing the position by 7,128 shares and retaining approximately 33,451 shares in the fund's portfolio.
American Healthcare REIT, a real estate investment trust formed through the October 1, 2021 merger of Griffin-American Healthcare REIT IV, Inc. with Griffin-American Healthcare REIT III, Inc., operates one of the sector's largest diversified healthcare real estate portfolios. As of December 31, 2025, the company held approximately 22.16 million square feet of clinical healthcare properties across its operating platform. The REIT generated trailing twelve-month revenue of $2.26 billion with net income attributable to common stockholders of $69.81 million and diluted earnings per share of $0.42.
Market positioning reflects strong institutional support, with the top four shareholders controlling approximately 33.68% of outstanding shares: The Vanguard Group (13.02%), BlackRock (12.83%), Wellington Management Group (4.13%), and Principal Global Investors (3.70%). The broader shareholder base includes 532 institutional owners with filed SEC positions. At current trading levels of $49.60 per share, AHR maintains a market capitalization of $9.52 billion with an enterprise value of $11.19 billion and a total debt-to-equity ratio of 50.20%.
Equity research coverage remains constructive despite headwinds. Truist Securities, maintaining a "Buy" rating as of March 13, 2026, raised its price target from $52 to $57, emphasizing AHR's competitive positioning and earnings growth outlook while acknowledging regulatory risks and tenant concentration exposure, particularly with operator Trilogy. The forward dividend yield stands at 2.00% based on an annualized distribution of $1.00 per share, with ex-dividend dates reflected in recent trading activity.
American Healthcare REIT, a real estate investment trust formed through the October 1, 2021 merger of Griffin-American Healthcare REIT IV, Inc. with Griffin-American Healthcare REIT III, Inc., operates one of the sector's largest diversified healthcare real estate portfolios. As of December 31, 2025, the company held approximately 22.16 million square feet of clinical healthcare properties across its operating platform. The REIT generated trailing twelve-month revenue of $2.26 billion with net income attributable to common stockholders of $69.81 million and diluted earnings per share of $0.42.
Market positioning reflects strong institutional support, with the top four shareholders controlling approximately 33.68% of outstanding shares: The Vanguard Group (13.02%), BlackRock (12.83%), Wellington Management Group (4.13%), and Principal Global Investors (3.70%). The broader shareholder base includes 532 institutional owners with filed SEC positions. At current trading levels of $49.60 per share, AHR maintains a market capitalization of $9.52 billion with an enterprise value of $11.19 billion and a total debt-to-equity ratio of 50.20%.
Equity research coverage remains constructive despite headwinds. Truist Securities, maintaining a "Buy" rating as of March 13, 2026, raised its price target from $52 to $57, emphasizing AHR's competitive positioning and earnings growth outlook while acknowledging regulatory risks and tenant concentration exposure, particularly with operator Trilogy. The forward dividend yield stands at 2.00% based on an annualized distribution of $1.00 per share, with ex-dividend dates reflected in recent trading activity.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.